The irritable bowel syndrome (IBS) treatment market was valued at US$ 2,153.89 million in 2020 and is projected to reach US$ 4,600.30 million by 2028; it is expected to grow at a CAGR of 10.1% from 2021 to 2028.
The major factors such as the increasing prevalence of irritable bowel syndrome diseases and rising research & development activities drive the market growth. However, the limited number of product availability and treatment inefficiency restrain the market growth. IBS is a common chronic condition that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than inflammatory bowel disease. It shows symptoms such as cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both at the same. If the symptoms are mild, they can be managed by changing stress, lifestyle, and diet. On the other side, severe symptoms are treated with medication and counseling.
In APAC, many measures have been implemented to contain the spread of novel coronavirus that causes COVID-19. The measures have disrupted the operations of many companies in various industries, including healthcare industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. Also, there has been a significant drop in in-patient and out-patient care in private hospital chains. To relieve healthcare systems, many clinics are postponing noncritical appointments. This scenario is hindering the growth of the irritable bowel syndrome (IBS) treatment.
Lucrative Regions for Irritable Bowel Syndrome (IBS) Treatment Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
Irritable bowel syndrome is a majorly observed chronic gastrointestinal condition that is caused due to disturbances in bowel habits and abdominal pain. The disease is also known as spastic colon, irritable colon, mucous colitis, and spastic colitis. Irritable bowel syndrome shows symptoms such as abdominal pain, constipation, diarrhea, and cramping. Health systems across the regions are witnessing considerable growth in the incidence of irritable bowel syndrome. A data published by International Foundation for Gastrointestinal Disorders states that among all IBS patients, about 40% patients have mild IBS, around 35% have moderate IBS, and an estimated 25% suffer from severe IBS. Many people don't recognize IBS symptoms.
Certain factors such as food allergies, developing stages of gastroenteritis, sporadic movements of colon, abnormal composition of serotonin in colon, and mild celiac disease are among the risk factors that can cause IBS. These factors are projected to accelerate the rate of IBS prevalence across the world. For instance, according to a study published on NCBI in 2018, IBS is estimated to affect around 10% to 16% of the US population each year. Such staggering prevalence of IBS is likely to boost the irritable bowel syndrome (IBS) treatment market during the forecast period.
Type-Based Insights
Based on type, the Irritable Bowel Syndrome (IBS) Treatment market is segmented into mixed IBS (IBS-M), IBS with diarrhea (IBS-D), and IBS with constipation (IBS-C). In 2020, mixed IBS (IBS-M) segment held the largest share of the market. Also, the same segment is anticipated to register the highest CAGR during the forecast period. The rising prevalence of IBS among women and men are anticipated to propel the demand for the medicines that can treat combined symptoms of constipation and diarrhea. The prevalence of IBS is higher in the aging population. Therefore, the demand for medicines to treat mixed IBS is likely to grow significantly during the forecast period,
Irritable Bowel Syndrome (IBS) Treatment Market, by Type – 2020 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Product-Based Insights
Based on product, the irritable bowel syndrome (IBS) treatment market is segmented into rifaximin, eluxadoline, lubiprostone, linaclotide, and others. The linaclotide segment held the largest share of the market in 2020. Also, the same segment is estimated to register the highest CAGR in the market during the forecast period. The market growth for the segment is attributed to the factors such as the increasing manufacturing of generic version of linaclotide and rising market consolidation for developing and commercializing linaclotide to treat IBS.
Distribution Channel-Based Insights
Based on distribution channel, the irritable bowel syndrome (IBS) treatment market is segmented into hospitals pharmacies, drug stores and retail pharmacies, and online pharmacies. In 2020, the hospitals pharmacies segment held the largest share of the market. However, the drug stores and retail pharmacies segment is expected to register the highest CAGR during the forecast period.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Irritable Bowel Syndrome (IBS) Treatment Market: Strategic Insights
Market Size Value in US$ 2,153.89 Million in 2020 Market Size Value by US$ 4,600.30 Million by 2028 Growth rate CAGR of 10.1% from 2021-2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Irritable Bowel Syndrome (IBS) Treatment Market: Strategic Insights
| Market Size Value in | US$ 2,153.89 Million in 2020 |
| Market Size Value by | US$ 4,600.30 Million by 2028 |
| Growth rate | CAGR of 10.1% from 2021-2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Companies operating in the irritable bowel syndrome (IBS) treatment market adopt the product innovations strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.
Irritable Bowel Syndrome (IBS) Treatment Market – by Type
- IBS with Diarrhea (IBS-D)
- IBS with Constipation (IBS-C)
- Mixed IBS (IBS-M)
Irritable Bowel Syndrome (IBS) Treatment Market – by Product
- Rifaximin
- Eluxadoline
- Linaclotide
- Lubiprostone
- Others
Irritable Bowel Syndrome (IBS) Treatment Market – by Distribution Channel
- Hospitals Pharmacies
- Drug Stores and Retail Pharmacies
- Online Pharmacies
Irritable Bowel Syndrome (IBS) Treatment Market– by Geography
North America
- US
- Canada
- Mexico
Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of APAC
Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of SCAM
Company Profiles
- Ironwood Pharmaceuticals, Inc.
- AbbVie.
- Sebela Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Alfasigma S.p.A.
- Astellas Pharma Inc.
- AstraZeneca
- Synthetic Biologics, Inc.
- Bausch + Lomb Incorporated
- Lannett Company Inc
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type , Product , and Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Irritable bowel syndrome (IBS) is a common disorder that affects the abdominal organ, large intestine. It is also known as spastic colon, mucous colitis, irritable colon, and spastic colitis. The condition is much different than inflammatory bowel disease. However, it is a chronic condition which a person must manage for a longer period. It shows symptoms such as cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both at the same. These symptoms can be managed by changing stress, lifestyle, and diet. And the more severe symptoms are treated with medication and counseling.
The factors that are driving growth of the market are increasing prevalence of irritable bowel syndrome diseases and increasing research & development activities.
The irritable bowel syndrome (IBS) treatment market majorly consists of the players such as Ironwood Pharmaceuticals, Inc., AbbVie., Sebela Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited, Alfasigma S.p.A., Astellas Pharma Inc., AstraZeneca, Synthetic Biologics, Inc., Bausch + Lomb Incorporated and Lannett Company Inc amongst others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Irritable Bowel Syndrome Treatment Market – By Type
1.3.2 Global Irritable Bowel Syndrome Treatment Market – By Product
1.3.3 Global Irritable Bowel Syndrome Treatment Market – By Distribution Channel
1.3.4 Global Irritable Bowel Syndrome Treatment Market – By Geography
2. Irritable Bowel Syndrome Treatment Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Irritable Bowel Syndrome Treatment Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Irritable Bowel Syndrome Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Irritable Bowel Syndrome and Associated Conditions
5.1.2 Increasing Number of FDA Approvals and Drug Developments
5.2 Key Market Restraints
5.2.1 Limited Number of Product Availability and Treatment Inefficiency
5.2.2 Disruptive Effect of Corona Virus on the Economy
5.3 Key Market Opportunities
5.3.1 Increasing Disposable Incomes of The Population
5.3.2 Proliferation of Pharmaceutical Sector in Emerging Markets
5.4 Future Trends
5.4.1 Development of Medical Devices for The Treatment of Irritable Bowel Syndrome
5.5 Impact Analysis
6. Irritable Bowel Syndrome Treatment Market – Global Analysis
6.1 Global Irritable Bowel Syndrome Treatment Market Revenue Forecast and Analysis
6.2 Global Irritable Bowel Syndrome Treatment Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Irritable Bowel Syndrome Treatment Market Analysis – By Type
7.1 Overview
7.2 Global Irritable Bowel Syndrome Treatment Market Share by Type 2020 & 2028 (%)
7.3 Mixed IBS (IBS-M)
7.3.1 Overview
7.3.2 Mixed IBS (IBS-M) Market Revenue and Forecast to 2028 (US$ Mn)
7.4 IBS with Diarrhea (IBS-D)
7.4.1.1 IBS with Diarrhea (IBS-D) Market Revenue and Forecast to 2028 (US$ Mn)
7.5 IBS with Constipation (IBS-C)
7.5.1.1 IBS with Constipation (IBS-C) Market Revenue and Forecast to 2028 (US$ Mn)
8. Irritable Bowel Syndrome Treatment Market Analysis – By Product
8.1 Overview
8.2 Global Irritable Bowel Syndrome Treatment Market Share by Product 2020 & 2028 (%)
8.3 Rifaximin
8.3.1 Overview
8.3.2 Rifaximin Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Eluxadoline
8.4.1 Overview
8.4.2 Eluxadoline Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Lubiprostone
8.5.1 Overview
8.5.2 Lubiprostone Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Linaclotide
8.6.1 Overview
8.6.2 Linaclotide Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Others
8.7.1 Overview
8.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
9. Irritable Bowel Syndrome Treatment Market Analysis – By Distribution Channel
9.1 Overview
9.2 Global Irritable Bowel Syndrome Treatment Market Share by Distribution Channel 2020 & 2028 (%)
9.3 Hospitals Pharmacies
9.3.1 Overview
9.3.2 Hospitals Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Drug Stores and Retail Pharmacies
9.4.1 Overview
9.4.2 Drug Stores and Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Online Pharmacies
9.5.1 Overview
9.5.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
10. Irritable Bowel Syndrome (IBS) Treatment Market – Geographical Analysis
10.1 North America: Irritable Bowel Syndrome (IBS) Treatment Market
10.1.1 Overview
10.1.2 North America: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.1.4 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.1.5 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.6 North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
10.1.7 US: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.1 US: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.7.2 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.1.7.3 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.1.7.4 US: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.8 Canada: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.1 Canada: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.8.2 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.1.8.3 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.1.8.4 Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.1.9 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.1 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.1.9.2 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.1.9.3 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.1.9.4 Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.2 Europe: Irritable Bowel Syndrome Treatment Market
10.2.1 Overview
10.2.2 Europe: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.2.4 Europe: Irritable Bowel Syndrome Treatment Market, by Product 2019–2028 (USD Million)
10.2.5 Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019–2028 (USD Million)
10.2.6 Europe: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
10.2.7 Germany: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.7.1 Germany: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.7.2 Germany: Irritable Bowel Syndrome Treatment Market, by Type 2019–2028 (USD Million)
10.2.7.3 Germany: Irritable Bowel Syndrome Treatment Market, by Product 2019–2028 (USD Million)
10.2.7.4 Germany: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019–2028 (USD Million)
10.2.8 UK: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.8.1 UK: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.8.2 UK: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.2.8.3 UK: Irritable Bowel Syndrome Treatment Market, by Product 2019–2028 (USD Million)
10.2.8.4 UK: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019–2028 (USD Million)
10.2.9 France: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.9.1 France: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.9.2 France: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.2.9.3 France: Irritable Bowel Syndrome Treatment Market, by Product 2019–2028 (USD Million)
10.2.9.4 France: Irritable Bowel Syndrome Treatment Market, by Distribution Channel 2019–2028 (USD Million)
10.2.10 Italy: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.10.1 Italy: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.10.2 Italy: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.2.10.3 Italy: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.2.10.4 Italy: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.11 Spain: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.11.1.1 Spain: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.11.2 Spain: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.2.11.3 Spain: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.2.11.4 Spain: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.2.12 Rest of Europe: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.12.1.1 Rest of Europe: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.2.12.2 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.2.12.3 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.2.12.4 Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.3 Asia Pacific: Irritable Bowel Syndrome Treatment Market
10.3.1 Overview
10.3.2 Asia Pacific: Irritable Bowel Syndrome Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.3.4 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.3.5 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
10.3.7 Japan: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.3.7.1.1 Japan: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.3.7.2 Japan: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.3.7.3 Japan: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.3.7.4 Japan: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.8 China: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.3.8.1.1 China: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.3.8.2 China: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.3.8.3 China: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.3.8.4 China: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.9 India
10.3.9.1.1 India: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.3.9.2 India: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.3.9.3 India: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.3.9.4 India: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.10 South Korea
10.3.10.1.1 South Korea: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.3.10.2 South Korea: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.3.10.3 South Korea: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.3.10.4 South Korea: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.11 Australia
10.3.11.1.1 Australia: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.3.11.2 Australia: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.3.11.3 Australia: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.3.11.4 Australia: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.3.12 Rest of Asia Pacific
10.3.12.1.1 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.3.12.2 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type, 2019–2028 (USD Million)
10.3.12.3 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product, 2019–2028 (USD Million)
10.3.12.4 Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market
10.4.1 Overview
10.4.2 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.4.4 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.4.5 Middle East and Africa: Irritable Bowel Syndrome (IBS), by Distribution Channel, 2019–2028 (USD Million)
10.4.6 Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
10.4.7 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.4.7.1 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.4.7.2 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.4.7.3 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.4.7.4 Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.8 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.4.8.1 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.4.8.2 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.4.8.3 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.4.8.4 South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.9 UAE: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.4.9.1 UAE: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.4.9.2 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.4.9.3 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.4.9.4 UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.4.10 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.4.10.1 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.4.10.2 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type, 2019–2028 (USD Million)
10.4.10.3 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product, 2019–2028 (USD Million)
10.4.10.4 Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel, 2019–2028 (USD Million)
10.5 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market
10.5.1 Overview
10.5.2 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
10.5.4 South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
10.5.5 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
10.5.5.1 South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
10.5.6 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
10.5.6.3 Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
10.5.6.4 Brazil: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
10.5.7 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.5.7.1 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.5.7.2 Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
10.5.7.3 Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
10.5.7.4 Argentina: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
10.5.8 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.5.8.1 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
10.5.8.2 Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
10.5.8.3 Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
10.5.8.4 Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Irritable Bowel Syndrome (IBS) Treatment Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Irritable Bowel Syndrome Treatment Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Ironwood Pharmaceuticals, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Sebela Pharmaceuticals, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Takeda Pharmaceutical Company Limited
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Alfasigma S.p.A.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Astellas Pharma Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 AstraZeneca
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Synthetic Biologics, Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 1Key Developments
13.8 Bausch Health Companies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Lannett Company Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 AbbVie Inc.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 2. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 3. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 4. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 5. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. US: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Irritable Bowel Syndrome (IBS) Anti-Allergy Drugs Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 13. Europe Irritable Bowel Syndrome Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Europe Irritable Bowel Syndrome Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 15. Europe Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 16. Germany Irritable Bowel Syndrome Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 17. Germany Irritable Bowel Syndrome Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 18. Germany Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 19. UK Irritable Bowel Syndrome Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 20. UK Irritable Bowel Syndrome Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 21. UK Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 22. France Irritable Bowel Syndrome Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 23. France Irritable Bowel Syndrome Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 24. France Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 25. Italy: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 26. Italy: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 27. Italy: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 28. Spain: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 29. Spain: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 30. Spain: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 31. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 32. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 34. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 35. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 36. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 37. Japan: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 38. Japan: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 39. Japan: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 40. China: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 41. China: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 42. China: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 43. India: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 44. India: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 45. India: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 46. South Korea: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 47. South Korea: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 48. South Korea: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 49. Australia: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 50. Australia: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 51. Australia: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Type– Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 55. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 56. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 57. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 58. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 59. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 60. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 61. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 62. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 63. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 64. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 65. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 66. UAE: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 67. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 68. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 70. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 71. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 73. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 74. Brazil Irritable Bowel Syndrome (IBS) Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 76. Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 77. Argentina Irritable Bowel Syndrome (IBS) Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 79. Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 80. Rest of South and Central America Irritable Bowel Syndrome (IBS) Treatment Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)
Table 82. Organic Developments Done by Companies
Table 83. Inorganic Developments Done By Companies
Table 84. Glossary of Terms, Irritable Bowel Syndrome (IBS) Treatment Market
LIST OF FIGURES
Figure 1. Irritable Bowel Syndrome Treatment Market Segmentation
Figure 2. Irritable Bowel Syndrome Treatment Market Segmentation, By Region
Figure 3. Irritable Bowel Syndrome Treatment Market Overview
Figure 4. Mixed IBS (IBS–M) is Expected to Show Remarkable Growth During Forecast Period
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Irritable Bowel Syndrome Treatment Market, by Geography (US$ Million)
Figure 7. Global Irritable Bowel Syndrome Treatment Market – Leading Country Markets (US$ Million)
Figure 8. Global Irritable Bowel Syndrome Treatment Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Global Irritable Bowel Syndrome Treatment Market – Revenue Forecast and Analysis – 2020- 2028
Figure 15. Global Irritable Bowel Syndrome Treatment Market – By Geography Forecast and Analysis – 2020- 2028
Figure 16. Market Positioning of Key Players in Global Irritable Bowel Syndrome Treatment Market
Figure 17. Global Irritable Bowel Syndrome Treatment Market Share by Type 2020 & 2028 (%)
Figure 18. Mixed IBS (IBS-M) Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. IBS with Diarrhea (IBS-D) Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. IBS with Constipation (IBS-C) Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. Global Irritable Bowel Syndrome Treatment Market Share by Product 2020 & 2028 (%)
Figure 22. Rifaximin Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. Eluxadoline Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. Lubiprostone Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 25. Linaclotide Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. Others Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. Global Irritable Bowel Syndrome Treatment Market Share by Distribution Channel 2020 & 2028 (%)
Figure 28. Hospitals Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 29. Drug Stores and Retail Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 30. Online Pharmacies Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 32. North America Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 33. North America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
Figure 34. US: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Canada: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Mexico: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Europe: Irritable Bowel Syndrome Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 38. Europe Irritable Bowel Syndrome Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 39. Europe: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
Figure 40. Germany: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. UK: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. France: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Italy: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 44. Spain: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 45. Rest of Europe: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 46. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 47. Asia Pacific: Irritable Bowel Syndrome Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 48. Asia Pacific: Irritable Bowel Syndrome Treatment Market, by Country, 2020 & 2028 (%)
Figure 49. Japan: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 50. China: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 51. India: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 52. South Korea: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 53. Australia: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 54. Rest of Asia Pacific: Irritable Bowel Syndrome Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 55. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 56. Middle East and Africa Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 57. Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
Figure 58. Saudi Arabia: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. South Africa: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. UAE: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. Rest of Middle East and Africa: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Key Country – Revenue (2020) (USD Million)
Figure 63. South and Central America Irritable Bowel Syndrome (IBS) Treatment Market Revenue and Forecast to 2028 (USD Million)
Figure 64. South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market, by Country, 2020 & 2028 (%)
Figure 65. Brazil: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. Argentina: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. Rest of South and Central America: Irritable Bowel Syndrome (IBS) Treatment Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Impact of COVID-19 Pandemic in North American Country Markets
Figure 69. Impact of COVID-19 Pandemic in Europe Country Markets
Figure 70. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 72. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 73. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Irritable Bowel Syndrome (IBS) Treatment Market
- Ironwood Pharmaceuticals, Inc.
- AbbVie.
- Sebela Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- Alfasigma S.p.A.
- Astellas Pharma Inc.
- AstraZeneca
- Synthetic Biologics, Inc.
- Bausch + Lomb Incorporated
- Lannett Company Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Irritable Bowel Syndrome (IBS) Treatment Market
May 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
May 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
May 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
May 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)